![The Pay 100: UK ARCHITECTURE SALARY ADVOCATE - A worker-led UK architecture organisation supporting and inspiring open wage cooperation, established in 2022. The Pay 100: UK ARCHITECTURE SALARY ADVOCATE - A worker-led UK architecture organisation supporting and inspiring open wage cooperation, established in 2022.](https://thepay100.org/wp-content/uploads/2022/11/7a173a306fe2ce3029175afeb190d894.jpeg)
The Pay 100: UK ARCHITECTURE SALARY ADVOCATE - A worker-led UK architecture organisation supporting and inspiring open wage cooperation, established in 2022.
![The Pay 100: UK ARCHITECTURE SALARY ADVOCATE - A worker-led UK architecture organisation supporting and inspiring open wage cooperation, established in 2022. The Pay 100: UK ARCHITECTURE SALARY ADVOCATE - A worker-led UK architecture organisation supporting and inspiring open wage cooperation, established in 2022.](https://thepay100.org/wp-content/uploads/2022/08/Logo_01-1-1024x576.jpg)
The Pay 100: UK ARCHITECTURE SALARY ADVOCATE - A worker-led UK architecture organisation supporting and inspiring open wage cooperation, established in 2022.
![Falconer Chester Hall improves its ranking in the Architects' Journal Top 100, a list of leading UK architectural practices. - Falconer Chester Hall Falconer Chester Hall improves its ranking in the Architects' Journal Top 100, a list of leading UK architectural practices. - Falconer Chester Hall](https://www.fcharchitects.com/wp-content/uploads/2020/06/AJ100.jpg)
Falconer Chester Hall improves its ranking in the Architects' Journal Top 100, a list of leading UK architectural practices. - Falconer Chester Hall
![Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of patients with rotator cuff disorders (GRASP): a multicentre, pragmatic, 2 × 2 factorial, randomised controlled trial - The Lancet Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of patients with rotator cuff disorders (GRASP): a multicentre, pragmatic, 2 × 2 factorial, randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/9a8d7733-aecd-4faf-ac54-00579afa93df/gr1.jpg)